Stay updated on Fazirsiran in AATD Liver Disease Clinical Trial

Sign up to get notified when there's something new on the Fazirsiran in AATD Liver Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fazirsiran in AATD Liver Disease Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The record now describes a completed Phase 2 study of fazirsiran for alpha-1 antitrypsin deficiency-associated liver disease, including its design, outcomes, eligibility criteria, and locations. It also provides posted study results and study documents.
    Difference
    58%
    Check dated 2026-11-09T13:44:14.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:46:24.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).
    Difference
    1%
    Check dated 2026-10-26T14:21:44.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov 403 page.
    Difference
    0.2%
    Check dated 2026-10-19T13:59:45.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer’s revision label changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:43:56.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study details view with an access-denied page and a Home link.
    Difference
    0.5%
    Check dated 2026-09-28T18:11:26.000Z thumbnail image

Stay in the know with updates to Fazirsiran in AATD Liver Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fazirsiran in AATD Liver Disease Clinical Trial page.